MONOPAR THERAPEUTICS INC's ticker is MNPR and the CUSIP is 61023L108. A total of 12 filers reported holding MONOPAR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $51,505 | -39.8% | 37,051 | +2.7% | 0.00% | – |
| Q4 2022 | $85,512 | +55.5% | 36,081 | -0.8% | 0.00% | – |
| Q3 2022 | $55,000 | -32.1% | 36,374 | +3.3% | 0.00% | – |
| Q2 2022 | $81,000 | -10.0% | 35,203 | -0.0% | 0.00% | – |
| Q1 2022 | $90,000 | -21.7% | 35,207 | -2.0% | 0.00% | – |
| Q4 2021 | $115,000 | -35.0% | 35,920 | -1.2% | 0.00% | – |
| Q3 2021 | $177,000 | -16.9% | 36,339 | +0.6% | 0.00% | – |
| Q2 2021 | $213,000 | -4.5% | 36,106 | +0.3% | 0.00% | – |
| Q1 2021 | $223,000 | -38.1% | 36,001 | -38.8% | 0.00% | – |
| Q4 2020 | $360,000 | +3.7% | 58,793 | -9.2% | 0.00% | – |
| Q3 2020 | $347,000 | -6.7% | 64,748 | +30.1% | 0.00% | – |
| Q2 2020 | $372,000 | – | 49,753 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Windsor Advisory Group, LLC | 89,974 | $55,775 | 0.13% |
| Rappaport Reiches Capital Management, LLC | 10,695 | $6,630 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,727 | $2,311 | 0.00% |
| JPMORGAN CHASE & CO | 4 | $2 | 0.00% |
| VANGUARD GROUP INC | 87,596 | $54,301 | 0.00% |
| UBS Group AG | 72 | $45 | 0.00% |
| WELLS FARGO & COMPANY/MN | 33 | $20 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 41,199 | $23,483 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 19,008 | $10,835 | 0.00% |